| Date Checked | 2025-12-21 23:44:10 |
|---|---|
| Graham Number | (PB)nan vs (PE)0.00 |
| Over / Under Value Percentage | 0.00% vs 0.00% |
| Dividend Yield | 0.00% |
| Dividend Date | None |
| Symbol | DNA |
| AssetType | Common Stock |
| Name | Ginkgo Bioworks Holdings |
| Description | None |
| CIK | 1830214 |
| Exchange | NYSE |
| Currency | USD |
| Country | USA |
| Sector | HEALTHCARE |
| Industry | BIOTECHNOLOGY |
| Address | 27 DRYDOCK AVENUE, BOSTON, MA, UNITED STATES, 02210 |
| OfficialSite | https://www.ginkgo.bio |
| FiscalYearEnd | December |
| LatestQuarter | 2025-09-30 |
| MarketCapitalization | 490781000 |
| EBITDA | -271924000 |
| PERatio | 0 |
| PEGRatio | None |
| BookValue | 9.85 |
| DividendPerShare | None |
| EPS | -6.18 |
| RevenuePerShareTTM | 3.305 |
| ProfitMargin | -1.88 |
| OperatingMarginTTM | -2.273 |
| ReturnOnAssetsTTM | -0.155 |
| ReturnOnEquityTTM | -0.5 |
| RevenueTTM | 180606000 |
| GrossProfitTTM | 131313000 |
| DilutedEPSTTM | -6.18 |
| QuarterlyEarningsGrowthYOY | 0 |
| QuarterlyRevenueGrowthYOY | -0.564 |
| AnalystTargetPrice | 10.67 |
| AnalystRatingStrongBuy | 0 |
| AnalystRatingBuy | 1 |
| AnalystRatingHold | 0 |
| AnalystRatingSell | 1 |
| AnalystRatingStrongSell | 2 |
| TrailingPE | - |
| ForwardPE | - |
| PriceToSalesRatioTTM | 2.717 |
| PriceToBookRatio | 0.877 |
| EVToRevenue | 2.502 |
| EVToEBITDA | -1.792 |
| Beta | 1.553 |
| 52WeekHigh | 17.58 |
| 52WeekLow | 5 |
| 50DayMovingAverage | 10.44 |
| 200DayMovingAverage | 9.97 |
| SharesOutstanding | 48523600 |
| SharesFloat | 40186100 |
| PercentInsiders | 3.469 |
| PercentInstitutions | 71.448 |
| ExDividendDate | None |
| dateChecked | 2025-12-21 23:44:10 |
| fresh | 1 |